New business practices drive down pharmaceutical costs
Pharmaceuticals have come a long way since Alexander Fleming discovered penicillin. These days, new wonder drugs, health care products and life-saving vaccines are produced every day. And at every stage of production – from research, development and manufacturing, to storage and transport – today’s medicines are made under sterile conditions and strict temperature and humidity levels.
Given the cost of developing a new drug and bringing it to a competitive market, the high level of research and development expenditures in the pharmaceutical industry are accelerating cost optimization throughout the supply chain.
In this context, one of the most effective strategies for optimizing costs is outsourcing, so pharmaceutical companies are able to prioritize their own internal capacities and enhance process efficiencies.
Throughout the supply chain, whether with a major pharmaceutical company or one of its CMO (Contract Manufacturing Organizations) partners, having an external partner is more efficient than investing in a lot of fixed assets, particularly with HVAC and other systems needed for temperature and humidity control.
It is no secret that every instrument, incubator, refrigerator and specimen need to be maintained under the right conditions – around the clock, every day of the year. A fluctuation of just one or two degrees can ruin years of research and work. That is why reliability and engineered solutions are a must.
In this white paper, you’ll learn how temporary power, cooling, chilling and dehumidification systems can overcome humidity challenges, assure worker’s comfort, comply production guidelines, improve efficiency and reduce capital expenditure outlays.